Mobile App-assisted Behavioral Treatment in Children and Adolescents With Tics

February 8, 2024 updated by: Judith Becker Nissen, Aarhus University Hospital

Mobile App-assisted Behavioral Treatment (MA-BT) in Children and Adolescents With an Impairing Tic Disorder. Randomized Clinical Trial Evaluating Treatment Response and Satisfaction

Chronic tic disorders are neurodevelopmental disorders affecting 0.5-1% of children and adolescents. Tics present as sudden, rapid, repetitive non-rhythmic movements or vocalizations or a combination. Tics may be extremely distressing in a child's life, but the severity of tics is often variable. The group of children/ adolescents with tic disorders are heterogenous when it comes to symptom presentation, comorbid conditions and social status. This places great demands on professionals to offer the right treatment at the right time. The aim of the current project is to make optimal tics training more accessible, including for patients managed in primary care, to make optimal treatment available in the immediate environment, and to ensure increased adherence to treatment.

As part of this project, an app has been developed and the study aims to evaluate mobile app-assisted behavioral treatment as an efficient and feasible approach that may be a valuable tool together with other treatment approaches. The mobile app-assisted training is based on the manual "Niks til Tics", which describes training with a combination of Habit Reversal Training (HRT) and Exposure Response Prevention (ERP) over nine sessions. Both HRT and ERP are known to be effective treatments of tics.

In this project a randomized controlled superiority trial evaluates the effect of app-assisted training versus an educational approach. Participants are randomized to manualised treatment combining HRT and ERP as app-assisted training, or to one session of psychoeducation supplemented with access to videos repeating the information. The participants are included according to the same criteria as in a pilot trial, and primary outcome measure is YGTSS at session 8. Furthermore, the change in tics intensity from baseline to randomization will be included as to evaluate the effect of being admitted and examined at the hospital.

This project contributes to increased knowledge about tics and tic treatment especially treatment using digital based interventions. An app has been developed for this project and the hypothesis is that a mobile app-assisted tic training program requiring minimal hospital contacts is superior to app-based psychoeducation alone, which is the most likely intervention that these patients will be offered.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: judith nissen, phd
  • Phone Number: +4529931523
  • Email: judiniss@rm.dk

Study Locations

    • Risskov
      • Aarhus N, Risskov, Denmark, 8240
        • Recruiting
        • AarhusUH
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 15 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • a primary diagnosis of either Tourette syndrome, chronic motor/vocal tics disorder or severe transient tics according to the WHO ICD-10 diagnostic criteria and Statistical Manual of Mental Disorders
  • a total score higher than 13 on the Yale Global Tic Severity Scale (YGTSS)

Exclusion Criteria:

  • psychotic disorder
  • primary severe depression
  • suicidal ideation or attempts
  • primary severe eating disorder
  • IQ below 70 (mental retardation)
  • participation in tic training based on HRT/ERP treatment within 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: digital tic training
The active treatment including apps released for every session
The app-assisted training group have access to a newly developed app in which they are taught how to handle tics. A new app session is released at each new treatment session and the content of the app videos is comparable to the information and training at face-to-face individual treatment, as defined by the manual "Niks to Tics"[
Active Comparator: digital tic learner
The control arm including apps released in the first session
The app-assisted training group have access to a newly developed app in which they are taught how to handle tics. A new app session is released at each new treatment session and the content of the app videos is comparable to the information and training at face-to-face individual treatment, as defined by the manual "Niks to Tics"[

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of baseline Yale Global Tic Severity Scale (YGTSS) at 16 weeks, 24 weeks, 40 weeks, 68 weeks
Time Frame: Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks
YGTSS - a clinician-administered semi-structured interview including a checklist of all tic symptoms
Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of baseline premonitory urge scale (PUTS)
Time Frame: Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks
PUTS is a short self-reporting scale with nine items
Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks
Change of baseline beliefs about tics scale (BATS)
Time Frame: Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks
BATS is a self-reporting scale with 20 items
Baseline, 6 weeks, 16 weeks, 24 weeks, 40 weeks, 68 weeks
Change of baseline parent and child self-evaluating questionnaire
Time Frame: Baseline, 16 weeks, 24 weeks, 40 weeks, 68 weeks
Based on PTQ - a parent evaluating questionnaire
Baseline, 16 weeks, 24 weeks, 40 weeks, 68 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Per Thomsen, Phd, Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Aarhus, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2022

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

May 1, 2022

First Submitted That Met QC Criteria

May 22, 2022

First Posted (Actual)

May 25, 2022

Study Record Updates

Last Update Posted (Estimated)

February 9, 2024

Last Update Submitted That Met QC Criteria

February 8, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tic Disorders

Clinical Trials on Mobile app-assisted behavioral treatment

3
Subscribe